TuHURA Biosciences, Inc. (HURA)
Nasdaq: HURA · Pharmaceutical Preparations · Tampa, FL · filing with the SEC since 2010
Filings
447 filings since 2017 beside 227 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 45 days after the quarter ended. The proxy statement was last filed Jul 9, 2026.
Filings a yearinsider forms included
112844537421017540
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Sep 17, 2026.Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Jan 30, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Jan 3, 2025.SEC letters: 16 in the last 36 months, the newest Sep 25, 2025.A late-filing notice, Form NT 10-K, filed Sep 30, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 17, 2026
8-K/A items 5.02, 9.01
Officer or director change · Current report, amended
Sep 10, 2026
Aug 19, 2026
8-K items 3.02, 5.07, 9.01
Shares sold without registration; Shareholder vote · Current report
Aug 18, 2026
May 15, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Apr 22, 2026
8-K items 1.01, 2.03, 3.02, 7.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Apr 21, 2026
Apr 8, 2026
8-K items 5.02, 8.01, 9.01
Officer or director change; Other event · Current report
Apr 2, 2026
Dec 10, 2025
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Dec 9, 2025
Dec 5, 2025
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
Dec 2, 2025
40 of 447 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.